Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Malaria Journal
Published in: Malaria Journal 1/2016

Open Access 01-12-2016 | Erratum

Erratum to: B cell sub-types following acute malaria and associations with clinical immunity

Authors: Richard T. Sullivan, Isaac Ssewanyana, Samuel Wamala, Felistas Nankya, Prasanna Jagannathan, Jordan W. Tappero, Harriet Mayanja-Kizza, Mary K. Muhindo, Emmanuel Arinaitwe, Moses Kamya, Grant Dorsey, Margaret E. Feeney, Eleanor M. Riley, Chris J. Drakeley, Bryan Greenhouse

Published in: Malaria Journal | Issue 1/2016

Login to get access

Excerpt

During production of the original article [1], an error occurred which resulted in the duplication of Richard T. Sullivan’s name within the author list. The original article [1] has been updated to present the correct author list, which also appears in this erratum. …
Literature
1.
Sullivan RT, Ssewanyana I, Wamala S, Nankya F, Jagannthan P, Tappero JW, et al. B cell sub-types following acute malaria and associations with clinical immunity. Malar J. 2016;15:139.CrossRefPubMedPubMedCentral
Metadata
Title
Erratum to: B cell sub-types following acute malaria and associations with clinical immunity
Authors
Richard T. Sullivan
Isaac Ssewanyana
Samuel Wamala
Felistas Nankya
Prasanna Jagannathan
Jordan W. Tappero
Harriet Mayanja-Kizza
Mary K. Muhindo
Emmanuel Arinaitwe
Moses Kamya
Grant Dorsey
Margaret E. Feeney
Eleanor M. Riley
Chris J. Drakeley
Bryan Greenhouse
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2016
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-016-1236-3

Other articles of this Issue 1/2016

Malaria Journal 1/2016 Go to the issue

Research

Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara

Research

Ecology of urban malaria vectors in Niamey, Republic of Niger

Methodology

Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity

Research

Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate–amodiaquine fixed dose combination or artemether–lumefantrine in Liberia

Review

Tying malaria and microRNAs: from the biology to future diagnostic perspectives

Research

Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether–lumefantrine drug pressure on Plasmodium falciparum populations in Senegal
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits